This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2009
Title: Lankeshwara Rao Matti: Innovator in Pharmaceutical Processes
Introduction
Lankeshwara Rao Matti is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. His work is recognized for its impact on the efficiency and effectiveness of pharmaceutical manufacturing.
Latest Patents
Lankeshwara Rao Matti holds a patent for a process titled "Process for preparing topotecan." This innovative process enhances the preparation of topotecan, a vital drug used in cancer treatment. His patent portfolio includes 1 patent, showcasing his commitment to advancing pharmaceutical technology.
Career Highlights
Matti is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading global pharmaceutical company. His role at Dr. Reddy's has allowed him to apply his expertise in drug formulation and process optimization. His contributions have been instrumental in the company's mission to provide affordable and accessible healthcare solutions.
Collaborations
Throughout his career, Lankeshwara Rao Matti has collaborated with esteemed colleagues, including Venkata Raghavendra Acharyulu Palle and Sekhar Munaswamy Nariyam. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical processes.
Conclusion
Lankeshwara Rao Matti is a distinguished inventor whose work in pharmaceutical processes has made a significant impact on drug development. His patent for the preparation of topotecan exemplifies his innovative spirit and dedication to improving healthcare. His contributions continue to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile